Skip to main content

Table 1 Baseline characteristics of eligible patients

From: Baicalin reduces blood lipids and inflammation in patients with coronary artery disease and rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial

  Baicalin (n = 166) Placebo (n = 165) P value
Age (years) 51.3 ± 4.2 52.1 ± 5.8 > 0.05
Gender (male/female) 74/92 67/98 > 0.05
BMI (kg/m2) 25.9 ± 4.1 26.3 ± 3.7 > 0.05
Smoking (n) 49 57 > 0.05
SBP (mmHg) 143.7 ± 7.6 148.2 ± 6.3 > 0.05
DBP (mmHg) 86.1 ± 8.3 89.4 ± 7.8 > 0.05
Time of RA diagnosis (years) 5.1 ± 2.4 5.8 ± 2.9 > 0.05
  1. Values are mean ± SD. BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure